- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Sebelius's Claim that Insurance Premiums are 16% Lower Than CBO Projected
Estimates from the nonpartisan Congressional Budget Office are considered the gold standard in Washington.
Estimates from the nonpartisan Congressional Budget Office are considered the gold standard in Washington. The budget impact of every bill voted on by Congress is calculated by CBO analysts — and their findings often make a difference in whether legislation passes or not.
That’s why politicians often tout CBO’s estimates. So we were curious last week when Secretary Sebelius cited a CBO projection of insurance rates — and how actual premiums turned out to be lower than expected. What’s the source of this factoid?
before
HHS directed The Fact Checker to a report released in September by the HHS Assistant Secretary for Planning and Evaluation (ASPE), which stated that “premiums tax credits will be more than 16 percent lower than projected.” The report explained that “the weighted average second lowest cost silver plan for 48 states (including DC) is 16 percent below projections based on the ASPE-derived Congressional Budget Office premiums.”
Read the full story here: http://wapo.st/1e38SeK
Source: The Washington Post
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
